AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Prophylaxis for mycoses is the next frontier for a variety of immune-compromised patient populations, according to noted mycologist John Graybill, MD, of Audie Murphy VA Hospital, San Antonio, Texas.
Speaking to an audience of experts at the Focus on Fungal Infections conference held in Phoenix, Arizona, Graybill said that "in five years, prophylaxis for fungal infection will probably be widespread."
Because patients with AIDS, transplant recipients, cancer patients, burn victims and individuals on long-term antibiotic therapy have compromised immune systems and cannot ward off fungal infections effectively, giving antifungal agents prophylactically will …